Inhibiting gluconeogenesis prevents fatty acid-induced increases in endogenous glucose production

Sylvia Kehlenbrink, Julia Tonelli, Sudha Koppaka, Visvanathan Chandramouli, Meredith A. Hawkins, Preeti Kishore

Research output: Contribution to journalArticle

13 Citations (Scopus)

Abstract

Glucose effectiveness, the ability of glucose per se to suppress endogenous glucose production (EGP), is lost in type 2 diabetes mellitus (T2DM). Free fatty acids (FFA) may contribute to this loss of glucose effectiveness in T2DM by increasing gluconeogenesis (GNG) and impairing the response to hyperglycemia. Thus, we first examined the effects of increasing plasma FFA levels for 3, 6, or 16 h on glucose effectiveness in nondiabetic subjects. Under fixed hormonal conditions, hyperglycemia suppressed EGP by 61% in nondiabetic subjects. Raising FFA levels with Liposyn infusion for ≥3 h reduced the normal suppressive effect of glucose by one-half. Second, we hypothesized that inhibiting GNG would prevent the negative impact of FFA on glucose effectiveness. Raising plasma FFA levels increased gluconeogenesis by ∼52% during euglycemia and blunted the suppression of EGP by hyperglycemia. Infusion of ethanol rapidly inhibited GNG and doubled the suppression of EGP by hyperglycemia, thereby restoring glucose effectiveness. In conclusion, elevated FFA levels rapidly increased GNG and impaired hepatic glucose effectiveness in nondiabetic subjects. Inhibiting GNG could have therapeutic potential in restoring the regulation of glucose production in type 2 diabetes mellitus.

Original languageEnglish (US)
JournalAmerican Journal of Physiology - Endocrinology and Metabolism
Volume297
Issue number1
DOIs
StatePublished - Jul 2009

Fingerprint

Gluconeogenesis
Fatty Acids
Glucose
Nonesterified Fatty Acids
Hyperglycemia
Type 2 Diabetes Mellitus
Ethanol

Keywords

  • Diabetes mellitus
  • Free fatty acids
  • Hyperglycemia

ASJC Scopus subject areas

  • Physiology
  • Physiology (medical)
  • Endocrinology, Diabetes and Metabolism

Cite this

Inhibiting gluconeogenesis prevents fatty acid-induced increases in endogenous glucose production. / Kehlenbrink, Sylvia; Tonelli, Julia; Koppaka, Sudha; Chandramouli, Visvanathan; Hawkins, Meredith A.; Kishore, Preeti.

In: American Journal of Physiology - Endocrinology and Metabolism, Vol. 297, No. 1, 07.2009.

Research output: Contribution to journalArticle

Kehlenbrink, Sylvia ; Tonelli, Julia ; Koppaka, Sudha ; Chandramouli, Visvanathan ; Hawkins, Meredith A. ; Kishore, Preeti. / Inhibiting gluconeogenesis prevents fatty acid-induced increases in endogenous glucose production. In: American Journal of Physiology - Endocrinology and Metabolism. 2009 ; Vol. 297, No. 1.
@article{99d84ef4698b48ec92c38c5c1b6e33d9,
title = "Inhibiting gluconeogenesis prevents fatty acid-induced increases in endogenous glucose production",
abstract = "Glucose effectiveness, the ability of glucose per se to suppress endogenous glucose production (EGP), is lost in type 2 diabetes mellitus (T2DM). Free fatty acids (FFA) may contribute to this loss of glucose effectiveness in T2DM by increasing gluconeogenesis (GNG) and impairing the response to hyperglycemia. Thus, we first examined the effects of increasing plasma FFA levels for 3, 6, or 16 h on glucose effectiveness in nondiabetic subjects. Under fixed hormonal conditions, hyperglycemia suppressed EGP by 61{\%} in nondiabetic subjects. Raising FFA levels with Liposyn infusion for ≥3 h reduced the normal suppressive effect of glucose by one-half. Second, we hypothesized that inhibiting GNG would prevent the negative impact of FFA on glucose effectiveness. Raising plasma FFA levels increased gluconeogenesis by ∼52{\%} during euglycemia and blunted the suppression of EGP by hyperglycemia. Infusion of ethanol rapidly inhibited GNG and doubled the suppression of EGP by hyperglycemia, thereby restoring glucose effectiveness. In conclusion, elevated FFA levels rapidly increased GNG and impaired hepatic glucose effectiveness in nondiabetic subjects. Inhibiting GNG could have therapeutic potential in restoring the regulation of glucose production in type 2 diabetes mellitus.",
keywords = "Diabetes mellitus, Free fatty acids, Hyperglycemia",
author = "Sylvia Kehlenbrink and Julia Tonelli and Sudha Koppaka and Visvanathan Chandramouli and Hawkins, {Meredith A.} and Preeti Kishore",
year = "2009",
month = "7",
doi = "10.1152/ajpendo.00001.2009",
language = "English (US)",
volume = "297",
journal = "American Journal of Physiology - Renal Fluid and Electrolyte Physiology",
issn = "1931-857X",
publisher = "American Physiological Society",
number = "1",

}

TY - JOUR

T1 - Inhibiting gluconeogenesis prevents fatty acid-induced increases in endogenous glucose production

AU - Kehlenbrink, Sylvia

AU - Tonelli, Julia

AU - Koppaka, Sudha

AU - Chandramouli, Visvanathan

AU - Hawkins, Meredith A.

AU - Kishore, Preeti

PY - 2009/7

Y1 - 2009/7

N2 - Glucose effectiveness, the ability of glucose per se to suppress endogenous glucose production (EGP), is lost in type 2 diabetes mellitus (T2DM). Free fatty acids (FFA) may contribute to this loss of glucose effectiveness in T2DM by increasing gluconeogenesis (GNG) and impairing the response to hyperglycemia. Thus, we first examined the effects of increasing plasma FFA levels for 3, 6, or 16 h on glucose effectiveness in nondiabetic subjects. Under fixed hormonal conditions, hyperglycemia suppressed EGP by 61% in nondiabetic subjects. Raising FFA levels with Liposyn infusion for ≥3 h reduced the normal suppressive effect of glucose by one-half. Second, we hypothesized that inhibiting GNG would prevent the negative impact of FFA on glucose effectiveness. Raising plasma FFA levels increased gluconeogenesis by ∼52% during euglycemia and blunted the suppression of EGP by hyperglycemia. Infusion of ethanol rapidly inhibited GNG and doubled the suppression of EGP by hyperglycemia, thereby restoring glucose effectiveness. In conclusion, elevated FFA levels rapidly increased GNG and impaired hepatic glucose effectiveness in nondiabetic subjects. Inhibiting GNG could have therapeutic potential in restoring the regulation of glucose production in type 2 diabetes mellitus.

AB - Glucose effectiveness, the ability of glucose per se to suppress endogenous glucose production (EGP), is lost in type 2 diabetes mellitus (T2DM). Free fatty acids (FFA) may contribute to this loss of glucose effectiveness in T2DM by increasing gluconeogenesis (GNG) and impairing the response to hyperglycemia. Thus, we first examined the effects of increasing plasma FFA levels for 3, 6, or 16 h on glucose effectiveness in nondiabetic subjects. Under fixed hormonal conditions, hyperglycemia suppressed EGP by 61% in nondiabetic subjects. Raising FFA levels with Liposyn infusion for ≥3 h reduced the normal suppressive effect of glucose by one-half. Second, we hypothesized that inhibiting GNG would prevent the negative impact of FFA on glucose effectiveness. Raising plasma FFA levels increased gluconeogenesis by ∼52% during euglycemia and blunted the suppression of EGP by hyperglycemia. Infusion of ethanol rapidly inhibited GNG and doubled the suppression of EGP by hyperglycemia, thereby restoring glucose effectiveness. In conclusion, elevated FFA levels rapidly increased GNG and impaired hepatic glucose effectiveness in nondiabetic subjects. Inhibiting GNG could have therapeutic potential in restoring the regulation of glucose production in type 2 diabetes mellitus.

KW - Diabetes mellitus

KW - Free fatty acids

KW - Hyperglycemia

UR - http://www.scopus.com/inward/record.url?scp=67650093470&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=67650093470&partnerID=8YFLogxK

U2 - 10.1152/ajpendo.00001.2009

DO - 10.1152/ajpendo.00001.2009

M3 - Article

C2 - 19417129

AN - SCOPUS:67650093470

VL - 297

JO - American Journal of Physiology - Renal Fluid and Electrolyte Physiology

JF - American Journal of Physiology - Renal Fluid and Electrolyte Physiology

SN - 1931-857X

IS - 1

ER -